141
142
143
Westgeest, Hans M., Kuppen, Malou C. P., van den Eertwegh, Alphonsus J. M., de Wit, Ronald, Coenen, Juleon L. L. M., van den Berg, H. P. (Pieter), Mehra, Niven, van Oort, Inge M., Fossion, Laurent M. C. L., Hendriks, Mathijs P., Bloemendal, Haiko J., van de Luijtgaarden, Addy C. M., Huinink, Daan ten Bokkel, van den Bergh, A. C. M. (Fons), van den Bosch, Joan, Polee, Marco B., Weijl, Nir, Bergman, Andre M., Uyl-de Groot, Carin A., Gerritsen, Winald R.
Veröffentlicht in: Westgeest , H M , Kuppen , M C P , van den Eertwegh , A J M , de Wit , R , Coenen , J L L M , van den Berg , H P , Mehra , N , van Oort , I M , Fossion , L M C L , Hendriks , M P , Bloemendal , H J , van de Luijtgaarden , A C M , Huinink , D T B , van den Bergh , A C M , van den Bosch , J , Polee , M B , Weijl , N , Bergman , A M , Uyl-de Groot , C A & Gerritsen , W R 2019 , ' Second-Line Cabazitaxel Treatment in Castration-Resistant Prostate Cancer Clinical Trials Compared to Standard of Care in CAPRI : Observational Study in the Netherlands ' , Clinical genitourinary cancer , vol. 17 , no. 5 , pp. E946-E956 . https://doi.org/10.1016/j.clgc.2019.05.018;
2019
Veröffentlicht in: Westgeest , H M , Kuppen , M C P , van den Eertwegh , A J M , de Wit , R , Coenen , J L L M , van den Berg , H P , Mehra , N , van Oort , I M , Fossion , L M C L , Hendriks , M P , Bloemendal , H J , van de Luijtgaarden , A C M , Huinink , D T B , van den Bergh , A C M , van den Bosch , J , Polee , M B , Weijl , N , Bergman , A M , Uyl-de Groot , C A & Gerritsen , W R 2019 , ' Second-Line Cabazitaxel Treatment in Castration-Resistant Prostate Cancer Clinical Trials Compared to Standard of Care in CAPRI : Observational Study in the Netherlands ' , Clinical genitourinary cancer , vol. 17 , no. 5 , pp. E946-E956 . https://doi.org/10.1016/j.clgc.2019.05.018;
2019
144
145
146
147
148
149
150
Wagner, Anna Dorothea, Grabsch, Heike, Mauer, Murielle, Marreaud, Sandrine, Caballero, Carmela, Thuss-Patience, Peter, Mueller, Lothar, Elme, Annelie, Moehler, Markus Hermann, Martens, Uwe, Kang, Yoon-Koo, Rha, Sun Young, Cats, Annemieke, Tokunaga, Masanori, Lordick, Florian
Veröffentlicht in: Wagner , A D , Grabsch , H , Mauer , M , Marreaud , S , Caballero , C , Thuss-Patience , P , Mueller , L , Elme , A , Moehler , M H , Martens , U , Kang , Y-K , Rha , S Y , Cats , A , Tokunaga , M & Lordick , F 2019 , ' EORTC-1203-GITCG - the "INNOVATION"-trial : Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group ' , BMC Cancer , vol. 19 , 494 . https://doi.org/10.1186/s12885-019-5675-4;
2019
Veröffentlicht in: Wagner , A D , Grabsch , H , Mauer , M , Marreaud , S , Caballero , C , Thuss-Patience , P , Mueller , L , Elme , A , Moehler , M H , Martens , U , Kang , Y-K , Rha , S Y , Cats , A , Tokunaga , M & Lordick , F 2019 , ' EORTC-1203-GITCG - the "INNOVATION"-trial : Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group ' , BMC Cancer , vol. 19 , 494 . https://doi.org/10.1186/s12885-019-5675-4;
2019